Litigation Details for Melucci v. Corcept Therapeutics Incorporated (N.D. Cal. 2019)
✉ Email this page to a colleague
Melucci v. Corcept Therapeutics Incorporated (N.D. Cal. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-03-14 |
| Court | District Court, N.D. California | Date Terminated | 2021-08-31 |
| Cause | 15:78m(a) Securities Exchange Act | Assigned To | Lucy Haeran Koh |
| Jury Demand | Plaintiff | Referred To | Susan G. Van Keulen |
| Parties | BUCKS COUNTY EMPLOYEES RETIREMENT FUND; CHARLES ROBB; CORCEPT THERAPEUTICS INCORPORATED; JAMES L. FERRARO; JOSEPH K. BELANOFF; LEAD PLAINTIFF FERRARO FAMILY FOUNDATION, INC.; NICHOLAS MELUCCI; NOVA SCOTIA HEALTH EMPLOYEES PENSION PLAN; ROBERT BAFFA; SEAN MADUCK | ||
| Patents | 6,218,343; 7,273,963; 7,963,864; 7,989,486; 8,486,940; 8,980,940; 9,586,994; 9,980,944 | ||
| Attorneys | Adam Christopher McCall; Adam Marc Apton; Andrea Pallios Roberts; Charles Henry Linehan; Danielle Suzanne Myers; Gregory Mark Nespole; J Alexander Hood , II; Jennifer Pafiti; Jeremy A Lieberman; Jesse A. Bernstein; Juan Carlos Sanchez; Laurence Matthew Rosen; Lesley F. Portnoy; Lionel Zevi Glancy; Matthew Laurence Tuccillo; Michael Kang; Patrick V. Dahlstrom; Pavithra Rajesh; Renita Nath Sharma; Richard Corey Worcester; Robert Vincent Prongay; Ryan A Fleisher; Sebastiano Tornatore; Shawn A. Williams; Terry Lee Wit | ||
| Firms | Glancy Binkow & Goldberg LLP; Glancy Prongay & Murray LLP; Levi & Korsinsky, LLP; Levi Korsinsky; Michael Kang; Pomerantz LLP; Quinn Emanuel; Quinn Emanuel Et Al LLP; Quinn Emanuel Urquhart & Sullivan, LLP; Quinn Emanuel Urquhart Oliver & Sullivan LLP; Robbins Geller Rudman & Dowd LLP; Ryan a Fleisher; The Rosen Law Firm, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Melucci v. Corcept Therapeutics Incorporated
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Biologic Drugs cited in Melucci v. Corcept Therapeutics Incorporated
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Melucci v. Corcept Therapeutics Incorporated (N.D. Cal. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-20 | 100 | Amended Complaint | $13,464,350.46 85.3% 10 2016 $6,218,343.16 $1,567,124.17 $4,651,218.99 …composition of matter patent has expired. Instead, Corcept relies on 10 patents covering the use of 19…covered by our patents. Although any such “off-label” use 8 would violate our patents, effectively…Corcept’s recently 21 issued ‘214 use patent 46 before the US Patent and Trademark Office (“USPTO”). On … only by a statutory stay pending 12 ongoing patent infringement litigation. 13 4. Despite | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
